Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease

Veronica Alfieri; Ernesto Crisafulli; Dina Visca; Wing Ho Chong; Carmel Stock; Letizia Mori; Angelo de Lauretis; Vicky Tsipouri; Felix Chua; Vasilis Kouranos; Maria Kokosi; Charlotte Hogben; Philip L. Molyneaux; Peter M. George; Toby M. Maher; Alfredo A. Chetta; Piersante Sestini; Athol U. Wells; Elisabetta A. Renzoni

doi:10.1183/13993003.01681-2019

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease

Veronica Alfieri, Ernesto Crisafulli, Dina Visca, Wing Ho Chong, Carmel Stock, Letizia Mori, Angelo de Lauretis, Vicky Tsipouri, Felix Chua, Vasilis Kouranos, Maria Kokosi, Charlotte Hogben, Philip L. Molyneaux, Peter M. George, Toby M. Maher, Alfredo A. Chetta, Piersante Sestini, Athol U. Wells, Elisabetta A. Renzoni

Istituti Clinici Scientifici Maugeri Spa – Società Benefit

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	1901681
Journal	European Respiratory Journal
Volume	55
Issue number	2
DOIs	https://doi.org/10.1183/13993003.01681-2019
Publication status	Published - Feb 1 2020

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/13993003.01681-2019

Cite this

Alfieri, V., Crisafulli, E., Visca, D., Chong, W. H., Stock, C., Mori, L., de Lauretis, A., Tsipouri, V., Chua, F., Kouranos, V., Kokosi, M., Hogben, C., Molyneaux, P. L., George, P. M., Maher, T. M., Chetta, A. A., Sestini, P., Wells, A. U., & Renzoni, E. A. (2020). Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease. European Respiratory Journal, 55(2), [1901681]. https://doi.org/10.1183/13993003.01681-2019

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease. / Alfieri, Veronica; Crisafulli, Ernesto; Visca, Dina; Chong, Wing Ho; Stock, Carmel; Mori, Letizia; de Lauretis, Angelo; Tsipouri, Vicky; Chua, Felix; Kouranos, Vasilis; Kokosi, Maria; Hogben, Charlotte; Molyneaux, Philip L.; George, Peter M.; Maher, Toby M.; Chetta, Alfredo A.; Sestini, Piersante; Wells, Athol U.; Renzoni, Elisabetta A.

In: European Respiratory Journal, Vol. 55, No. 2, 1901681, 01.02.2020.

Research output: Contribution to journal › Letter › peer-review

Alfieri, V, Crisafulli, E, Visca, D, Chong, WH, Stock, C, Mori, L, de Lauretis, A, Tsipouri, V, Chua, F, Kouranos, V, Kokosi, M, Hogben, C, Molyneaux, PL, George, PM, Maher, TM, Chetta, AA, Sestini, P, Wells, AU & Renzoni, EA 2020, 'Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease', European Respiratory Journal, vol. 55, no. 2, 1901681. https://doi.org/10.1183/13993003.01681-2019

Alfieri, Veronica ; Crisafulli, Ernesto ; Visca, Dina ; Chong, Wing Ho ; Stock, Carmel ; Mori, Letizia ; de Lauretis, Angelo ; Tsipouri, Vicky ; Chua, Felix ; Kouranos, Vasilis ; Kokosi, Maria ; Hogben, Charlotte ; Molyneaux, Philip L. ; George, Peter M. ; Maher, Toby M. ; Chetta, Alfredo A. ; Sestini, Piersante ; Wells, Athol U. ; Renzoni, Elisabetta A. / Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease. In: European Respiratory Journal. 2020 ; Vol. 55, No. 2.

@article{66465ffc1a504e20912deb995fa65920,

title = "Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease",

author = "Veronica Alfieri and Ernesto Crisafulli and Dina Visca and Chong, {Wing Ho} and Carmel Stock and Letizia Mori and {de Lauretis}, Angelo and Vicky Tsipouri and Felix Chua and Vasilis Kouranos and Maria Kokosi and Charlotte Hogben and Molyneaux, {Philip L.} and George, {Peter M.} and Maher, {Toby M.} and Chetta, {Alfredo A.} and Piersante Sestini and Wells, {Athol U.} and Renzoni, {Elisabetta A.}",

note = "Funding Information: Conflict of interest: V. Alfieri has nothing to disclose. E. Crisafulli has nothing to disclose. D. Visca has nothing to disclose. W.H. Chong has nothing to disclose. C. Stock has nothing to disclose. L. Mori has nothing to disclose. A. de Lauretis has nothing to disclose. V. Tsipouri has nothing to disclose. F. Chua reports lecture fees and advisory board fees from Boehringer Ingelheim and from Roche, outside the submitted work. V. Kouranos has nothing to disclose. M. Kokosi has nothing to disclose. C. Hogben has nothing to disclose. P.L. Molyneaux has, via his institution, received industry-academic funding from Roche, Boehringer Ingelheim and Galapagos and has received speaker fees from Roche. P.M. George reports grants, personal fees and non-financial support from Boehringer Ingelheim, personal fees and non-financial support from Roche, personal fees from Teva, outside the submitted work. T.M. Maher has, via his institution, received industry-academic funding from GlaxoSmithKline R&D and UCB and has received consultancy or speaker fees from Apellis, AstraZeneca, Bayer, Blade Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Galapagos, GlaxoSmithKline R&D, Indalo, Novartis, Pliant, ProMetic, Respivnat, Roche, Samumed and UCB. A.A. Chetta has nothing to disclose. P. Sestini has nothing to disclose. A.U. Wells reports lecture fees and advisory board fees from Boeringher Ingelheim, Roche and Bayer, outside the submitted work. E.A. Renzoni reports lecture fees and advisory board fees from Boeringher Ingelheim and Roche, and lecture fees from Mundipharma, outside the submitted work. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = feb,

day = "1",

doi = "10.1183/13993003.01681-2019",

language = "English",

volume = "55",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "2",

}

TY - JOUR

T1 - Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease

AU - Alfieri, Veronica

AU - Crisafulli, Ernesto

AU - Visca, Dina

AU - Chong, Wing Ho

AU - Stock, Carmel

AU - Mori, Letizia

AU - de Lauretis, Angelo

AU - Tsipouri, Vicky

AU - Chua, Felix

AU - Kouranos, Vasilis

AU - Kokosi, Maria

AU - Hogben, Charlotte

AU - Molyneaux, Philip L.

AU - George, Peter M.

AU - Maher, Toby M.

AU - Chetta, Alfredo A.

AU - Sestini, Piersante

AU - Wells, Athol U.

AU - Renzoni, Elisabetta A.

N1 - Funding Information: Conflict of interest: V. Alfieri has nothing to disclose. E. Crisafulli has nothing to disclose. D. Visca has nothing to disclose. W.H. Chong has nothing to disclose. C. Stock has nothing to disclose. L. Mori has nothing to disclose. A. de Lauretis has nothing to disclose. V. Tsipouri has nothing to disclose. F. Chua reports lecture fees and advisory board fees from Boehringer Ingelheim and from Roche, outside the submitted work. V. Kouranos has nothing to disclose. M. Kokosi has nothing to disclose. C. Hogben has nothing to disclose. P.L. Molyneaux has, via his institution, received industry-academic funding from Roche, Boehringer Ingelheim and Galapagos and has received speaker fees from Roche. P.M. George reports grants, personal fees and non-financial support from Boehringer Ingelheim, personal fees and non-financial support from Roche, personal fees from Teva, outside the submitted work. T.M. Maher has, via his institution, received industry-academic funding from GlaxoSmithKline R&D and UCB and has received consultancy or speaker fees from Apellis, AstraZeneca, Bayer, Blade Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Galapagos, GlaxoSmithKline R&D, Indalo, Novartis, Pliant, ProMetic, Respivnat, Roche, Samumed and UCB. A.A. Chetta has nothing to disclose. P. Sestini has nothing to disclose. A.U. Wells reports lecture fees and advisory board fees from Boeringher Ingelheim, Roche and Bayer, outside the submitted work. E.A. Renzoni reports lecture fees and advisory board fees from Boeringher Ingelheim and Roche, and lecture fees from Mundipharma, outside the submitted work. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/2/1

Y1 - 2020/2/1

UR - http://www.scopus.com/inward/record.url?scp=85081144837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081144837&partnerID=8YFLogxK

U2 - 10.1183/13993003.01681-2019

DO - 10.1183/13993003.01681-2019

M3 - Letter

C2 - 31699833

AN - SCOPUS:85081144837

VL - 55

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 2

M1 - 1901681

ER -